This program offers 1 participatory MCLE credit. You must register in advance to participate.
Presented by the Patent Interest Group.
This webinar offers the latest developments involving Section 285, covering cases in which attorneys’ fees were awarded based on (1) pre-litigation investigation and (2) PTAB filings, and cases granting fees before the Court of Federal Claims and denying fees on appeal.
Moderator: Alex Chan
Matt Rizzolo is a partner in Ropes & Gray’s Intellectual Property Litigation group, resident in the firm’s Washington, D.C. office. Matt works extensively with technology companies to both enforce clients’ intellectual property rights and defend clients from patent infringement claims. He has significant experience litigating patent cases in a variety of jurisdictions, including federal district courts throughout the United States and in Section 337 actions before the United States International Trade Commission. His practice encompasses all facets of litigation, from pre-suit investigation through managing document discovery, taking and defending fact and expert depositions, claim construction, motions practice, trial preparation, trial, and post-trial proceedings. Matt has counseled clients in cases involving a wide variety of technical fields, including smartphones, video gaming devices, computer software and hardware, telecommunications, and Internet-related services. He frequently comments in the media, publishes articles, and podcasts on noteworthy intellectual property matters. While at a prior law firm, Matt also co-founded and wrote for The Essential Patent Blog, a legal blog that focuses on issues relating to standard-essential patents.
Joseph R. Robinson, a partner at Troutman Sanders, helps clients resolve a range of intellectual property challenges with his deep legal experience and business acumen. He advises both at a strategic level and on day-to-day issues to ensure clients derive maximum value from their IP assets. Joe represents clients in a variety of patent and trademark disputes throughout the United States, and as appellate counsel before the Court of Appeals for the Federal Circuit. Joe has more than 30 years of experience in all aspects of intellectual property law. He focuses his practice in the pharmaceutical, life sciences, biotechnology and medical device fields. His practice encompasses litigation, including Hatch-Waxman and biosimilar litigation; inter partes proceedings; licensing; counseling; due diligence; patent and trademark prosecution and strategy; and mergers and acquisitions. Joe is an advisor on life sciences to the White House Office of American Innovation and is a reviewer for the peer-reviewed Nature Biotechnology. He also covers Federal Circuit matters for IP Watchdog. Joe has been intellectual property counsel on more than $110 billion in mergers, acquisitions and licenses for big pharma, midsize pharma, small pharma and startups. His services include strategic issues, valuation, structuring, negotiations and drafting.